Literature DB >> 28781292

Comparison of the Benefit Feeling Rate Based on the Sho of OTC Kakkonto, Cold Remedy and Cold Remedy with Kakkonto Combination Product.

Mitsuyoshi Okita1, Yuki Yayoshi2, Kousuke Ohara3, Akio Negishi2, Hayato Akimoto2, Naoko Inoue1,4, Sachihiko Numajiri4, Shigeru Ohshima1,4, Seiichi Honma5, Shinji Oshima2, Daisuke Kobayashi1,2.   

Abstract

Kakkonto (KK), a traditional Japanese Kampo formulation for cold and flu, is generally sold as an OTC pharmaceuticals used for self-medication. Kampo formulations should be used according to the Sho-symptoms of Kampo medicine. These symptoms refer to the subjective symptoms themselves. Although with OTC pharmaceuticals, this is often not the case. We surveyed the relationship of agreement of Sho with the benefit feeling rate (BFR) of patients who took KK (n=555), cold remedies with KK (CK, n=315), and general cold remedies (GC, n=539) using internet research. BFR of a faster recovery was greater in participants who took the medication early and who had confidence in their physical strength in all treatment groups. BFR was significantly higher in the GC group than in the KK group for patients with headache, runny nose, blocked nose, sneezing, and cough. BFR was also significantly higher in the GC group than in the CK group for headache (males) and cough (females). BFR was the highest in the KK group for stiff shoulders. All cold remedies were more effective when taken early, and the larger the number of Sho that a patient had, the greater the BFR increased. Therefore, a cold remedy is expected to be most effective when there are many cold symptoms and when it is taken at an early stage of the common cold.

Entities:  

Keywords:  OTC pharmaceutical; Sho; benefit feeling rate; cold remedy; internet survey; kakkonto

Mesh:

Substances:

Year:  2017        PMID: 28781292     DOI: 10.1248/bpb.b17-00340

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  1 in total

1.  Discrepancies between patients' and pharmacists' perceptions of the role of community pharmacists as advisors on the use of pharmaceuticals in Japan: A comparison prior to and following revision of the Pharmacists' Act.

Authors:  Shinji Oshima; Mari Yamagishi; Mitsuyoshi Okita; Hayato Akimoto; Akio Negishi; Norimitsu Horii; Mizue Mutoh; Yasuko Sannomaru; Sachihiko Numajiri; Naoko Inoue; Shigeru Ohshima; Masahiro Wada; Daisuke Kobayashi
Journal:  SAGE Open Med       Date:  2019-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.